The Japan Times - Natural immunity more potent than vaccines during US Delta wave: study

EUR -
AED 4.168164
AFN 81.122003
ALL 98.671748
AMD 442.507784
ANG 2.045256
AOA 1039.486014
ARS 1330.848211
AUD 1.773251
AWG 2.042657
AZN 1.926696
BAM 1.952865
BBD 2.290698
BDT 137.842863
BGN 1.955708
BHD 0.427723
BIF 3330.66653
BMD 1.13481
BND 1.482299
BOB 7.839358
BRL 6.442276
BSD 1.134515
BTN 95.879457
BWP 15.530935
BYN 3.712786
BYR 22242.270527
BZD 2.278916
CAD 1.565186
CDF 3260.308462
CHF 0.934079
CLF 0.028143
CLP 1079.987008
CNY 8.251598
CNH 8.245499
COP 4792.630546
CRC 573.048978
CUC 1.13481
CUP 30.072458
CVE 110.785823
CZK 24.956731
DJF 201.678683
DKK 7.46513
DOP 66.783843
DZD 150.490527
EGP 57.684641
ERN 17.022146
ETB 149.624398
FJD 2.563478
FKP 0.847022
GBP 0.850494
GEL 3.115014
GGP 0.847022
GHS 17.374125
GIP 0.847022
GMD 81.12789
GNF 9821.777978
GTQ 8.737025
GYD 238.076438
HKD 8.801323
HNL 29.306411
HRK 7.531772
HTG 148.219882
HUF 404.72981
IDR 18794.718596
ILS 4.130616
IMP 0.847022
INR 96.011541
IQD 1486.600734
IRR 47789.683388
ISK 145.68677
JEP 0.847022
JMD 179.600115
JOD 0.804804
JPY 162.176785
KES 146.956976
KGS 99.239097
KHR 4541.507987
KMF 490.521187
KPW 1021.285951
KRW 1617.325186
KWD 0.347728
KYD 0.945496
KZT 582.210503
LAK 24534.58653
LBP 101622.210291
LKR 339.615645
LRD 226.422901
LSL 21.061893
LTL 3.350798
LVL 0.686435
LYD 6.190405
MAD 10.510891
MDL 19.47408
MGA 5117.991652
MKD 61.511705
MMK 2382.410181
MNT 4054.992006
MOP 9.064638
MRU 45.0803
MUR 51.247972
MVR 17.478028
MWK 1970.029319
MXN 22.240501
MYR 4.896707
MZN 72.63943
NAD 21.061928
NGN 1819.134185
NIO 41.638687
NOK 11.795711
NPR 153.412255
NZD 1.911269
OMR 0.436821
PAB 1.134515
PEN 4.160783
PGK 4.57385
PHP 63.284908
PKR 318.938443
PLN 4.283884
PYG 9086.585797
QAR 4.132407
RON 4.977387
RSD 117.152104
RUB 93.053547
RWF 1608.025374
SAR 4.25663
SBD 9.488482
SCR 16.141929
SDG 681.459659
SEK 10.964112
SGD 1.481613
SHP 0.891782
SLE 25.81704
SLL 23796.374013
SOS 648.542066
SRD 41.814301
STD 23488.270048
SVC 9.926733
SYP 14754.126111
SZL 21.0621
THB 37.895855
TJS 11.957742
TMT 3.983182
TND 3.374952
TOP 2.657841
TRY 43.675756
TTD 7.684588
TWD 36.35647
TZS 3052.637913
UAH 47.063537
UGX 4155.901413
USD 1.13481
UYU 47.736584
UZS 14690.11156
VES 98.215637
VND 29510.726789
VUV 136.641768
WST 3.141606
XAF 654.984298
XAG 0.034741
XAU 0.000343
XCD 3.06688
XDR 0.813352
XOF 652.515286
XPF 119.331742
YER 278.085629
ZAR 21.093111
ZMK 10214.64531
ZMW 31.568119
ZWL 365.408267
  • RBGPF

    -0.4500

    63

    -0.71%

  • CMSC

    -0.0530

    22.187

    -0.24%

  • SCS

    -0.0400

    9.97

    -0.4%

  • RYCEF

    -0.3500

    9.9

    -3.54%

  • NGG

    -0.0450

    72.995

    -0.06%

  • VOD

    0.1750

    9.755

    +1.79%

  • CMSD

    -0.0850

    22.265

    -0.38%

  • RIO

    -1.5300

    59.35

    -2.58%

  • RELX

    0.8500

    54.64

    +1.56%

  • GSK

    0.6900

    39.66

    +1.74%

  • BTI

    0.8450

    43.705

    +1.93%

  • AZN

    0.2500

    71.96

    +0.35%

  • JRI

    -0.0200

    12.91

    -0.15%

  • BCC

    -2.0400

    92.46

    -2.21%

  • BCE

    0.2500

    22.17

    +1.13%

  • BP

    -0.6650

    27.405

    -2.43%

Natural immunity more potent than vaccines during US Delta wave: study
Natural immunity more potent than vaccines during US Delta wave: study

Natural immunity more potent than vaccines during US Delta wave: study

During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.

Text size:

The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).

The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.

Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.

"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.

"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.

The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.

It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.

Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.

- Selection bias? -

By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.

In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.

Protection was highest among those who had both vaccination and prior Covid.

The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.

Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.

But the US CDC had previously taken the opposite position, based on pre-Delta data.

"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.

K.Yoshida--JT